期刊文献+

结肠癌复发转移相关因素分析 被引量:2

在线阅读 下载PDF
导出
摘要 目的探讨结肠癌术后复发转移临床病理因素。方法应用单因素和Cox模型多因素分析方法回顾性分析我院2004年10月~2010年2月收治并随访记录的结肠癌患者215例,所有病例均经病理证实且资料完整。结果单因素分析结果显示:梗阻、肿瘤部位、肿廇最大直经、Dukes’分期、淋巴结转移、组织学类型、分化程度、术前CEA均与复发转移有关;单因素分析有意义的变量进行Cox多因素分析显示:梗阻、Dukes’分期、淋巴结转移、组织学类型、分化程度与复发转移有关;化疗对B期无统计学意义,对C期有统计学意义。结论梗阻、Dukes分期、淋巴结转移、组织学类型、分化程度是复发转移独立预后因素,淋巴结转移是最大危险因素,其次为梗阻。
出处 《江西医药》 CAS 2010年第7期659-661,共3页 Jiangxi Medical Journal
  • 相关文献

参考文献10

  • 1Shane E,Hendon Jack A,Dipalma US.Practices for Colon Cancer Sceening J.Keio J Med,2005,54(4):179.
  • 2Read TE,Mutch MG,Chang BW,et al.Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon.J AM Coll Surg,2002,195:33.
  • 3Killingback M,Barron P,Dent OF.Local recurrence after curative res-ection of the rectum without total mesorectal excision.Dis Colon Rectum,2001,44(4):473.
  • 4夏振龙.结直肠癌肝转移的诊断与治疗[J].中国实用外科杂志,1999,19:579-581.
  • 5王汉涛,傅传刚,孟荣贵,金国祥,徐洪莲,于恩达,崔龙,邱群.结肠癌术后复发36例临床分析[J].中国实用外科杂志,2004,24(7):415-417. 被引量:19
  • 6杜寒松,王国斌,秦青平,夏玉春,陶荣盛,司徒光伟.结肠癌复发因素的多元回归分析[J].华中科技大学学报(医学版),2004,33(3):343-346. 被引量:15
  • 7Tomisaki S.Ohno S.Ichiyoshi Y.et al.Microvessel quantification and its possible relation with liver metastasis in colorectal cancer J.Cancer.1996.77(8 Suppl):1722.
  • 8Laso CA,Gonzalez JJ,Fresno F,et al,Prognostic value of micrometastases in esophageal and colorectal carcinoma(a clinical experience).Hepatogastroenterology,2004,51(58):964.
  • 9安大立,李志霞,吴江平,韩加刚.结直肠癌临床病理特征与复发和转移的相关性研究[J].中华胃肠外科杂志,2004,7(6):450-452. 被引量:6
  • 10Demols A,Van Laethem J L.Adjuvant chemotherapy for colorectal cancer.Curr Gastroenterol Rep,2002,4(5):420.

二级参考文献21

  • 1吴琼华,朱永廉.左咪唑用于结肠癌术后辅助治疗(综述)[J].浙江医科大学学报,1994,23(4):191-192. 被引量:3
  • 2PonzdeLeon M,Sant M,Micheli A et al.Clinical and pathologic prognostic indicators in colorectal cancer: a population based study.Cancer,1992,69: 626
  • 3Smothers L,Hynan L,Fleming J et al.Emergency surgery for colon carcinoma.Dis Colon Rectum,2003 ,46:24
  • 4Wolmark N,Rockette H,Fisher B et al.The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.J Clin Oncol,1993,11: 1879
  • 5Moertel C G,Fleming T R,Macdonald J S et al.Fluorouracil plus levamisole as effective adjuvant therapy after resectionof stage Ⅲ colon carcinoma: a final report.Ann Intern Med,1995,122: 321
  • 6Demols A,Van Laethem J L.Adjuvant chemotherapy for colorectal cancer.Curr Gastroenterol Rep,2002,4:420
  • 7de Gramont A,Vignoud J,Tournigand C et al.Oxaliplatin with high doseleucovorin and 5 fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer.Eur J Cancer,1997,33 :214
  • 8Troisi RJ,Freedman AN,Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer, 1999,85(8): 1670-1676
  • 9Ulanska J, Dziki A, Langner E, et al. Risk factors in the recurrence of the colorectal cancer. Acta Chir Iugosl, 2002,49(2): 41-43
  • 10Harris GJ, Church JM, Senagore AJ, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum, 2002 ,45(8): 1029-1034

共引文献35

同被引文献6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部